Abacus Life, Inc. ((ABX)) has held its Q1 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Abacus Life, Inc. struck an optimistic tone on its latest earnings call, highlighting strong revenue growth, expanding profitability and a dramatic swing in operating cash flow. Management emphasized that deliberate investments and some margin pressure are being made from a position of strength, arguing that fundraising traction, robust portfolio performance and rising guidance signal a company gaining momentum as it scales.
Raised Guidance Underscores Confidence
Abacus lifted its full‑year 2026 adjusted net income outlook to a range of $100 million to $106 million, implying adjusted EPS between $1.00 and $1.05. The company also set a Q2 target of $24 million to $26 million in adjusted net income, or $0.24 to $0.26 per share, framing the new guidance as a reflection of both recent performance and visibility into its pipeline.
Revenue Surges on Life Solutions and Fees
Total revenue climbed 34.6% year over year to $59.4 million in Q1 2026, up from $44.1 million. Management credited the increase primarily to Life Solutions revenue of $50.6 million and asset management fees of $8.5 million, underscoring the growing contribution of both core policy activities and recurring fee income.
Profitability Strength in Adjusted and GAAP Metrics
Adjusted net income rose 16.6% to $20.1 million in Q1 2026, while adjusted EBITDA jumped 33.3% to $32.7 million, yielding a 55% margin. GAAP net income attributable to Abacus reached $7.3 million, up 59%, translating to $0.07 per diluted share and signaling progress in reported earnings alongside adjusted results.
Operating Cash Flow Swings Sharply Positive
The company generated $91.7 million in operating cash flow in Q1 2026, a dramatic improvement from negative $61.6 million a year earlier. Management linked the more than $153 million swing to stronger policy cash flows, the wind‑up of a fund vehicle and better operating leverage as scale builds.
Fundraising and Pipeline Activity Accelerate
Abacus reported raising $288 million into its longevity funds in Q1, following $275 million in the prior quarter. The firm reviewed about 9,000 qualified policies during the period, nearly matching the total volume seen throughout all of 2025, and said new fund vintages have attracted nearly $1 billion since inception.
Portfolio KPIs Outperform Targets
Average realized gains reached 26% for the quarter, comfortably ahead of the company’s 20% target. The portfolio also maintained an annualized turnover of 1.9 times within a preferred range, with seasoned assets showing a weighted average life expectancy of 46 months and a weighted average insured age of 88 years.
LMA Income II Fund Wind‑Up Boosts Credibility
The LMA Income II fund, with roughly $115 million in assets under management, reached the end of its initial term and returned capital to investors fully on time. About one‑third of investors extended and another third reinvested, which management said demonstrates confidence in the platform while simplifying its consolidated fund reporting.
Balance Sheet Metrics and Capital Flexibility
Abacus ended the quarter with $37.2 million in cash and $392.8 million of balance sheet policy assets, while reported long‑term debt stood near $330 million after a reduction tied to fund deconsolidation. The firm highlighted an adjusted return on equity of 19% and adjusted return on invested capital of 17%, with recourse debt‑to‑EBITDA around two times and room to lever higher if needed.
Strategic Growth Initiatives Advance
Management outlined ongoing progress on a distribution partnership with Manning & Napier, expecting initial contributions beginning in Q2. The company is also targeting a second securitization in late Q2 or early Q3 to recycle capital and broaden its funding sources, positioning the platform for additional growth.
Operating Expenses Rise with Growth Investments
Total operating expenses reached approximately $34.8 million in Q1 2026, up from $19.6 million a year earlier when excluding certain fair value impacts. Executives characterized the higher sales, marketing, general and administrative, acquisition and special project costs as intentional investments to support future scale, though they acknowledged the step‑up is notable.
Margins See Slight Compression
Despite strong EBITDA growth, the adjusted EBITDA margin dipped slightly to 55% from 56% in the prior‑year quarter. Management portrayed the modest compression as a temporary by‑product of elevated growth spending and suggested that scaling revenues should help stabilize profitability over time.
Leverage and Liquidity Require Ongoing Management
The company noted that its roughly $330 million in reported long‑term debt remains substantial, and that the recent reduction largely reflects accounting changes from fund consolidation. With cash of $37.2 million, Abacus emphasized the importance of continued monetization of assets and careful financing strategy as deployment and securitization activity expand.
Execution Risks Around Securitization and New Products
A planned second securitization could shift from late Q2 into Q3, adding some timing risk to capital recycling plans. The firm also pointed to ongoing regulatory review of its interval fund, with no fixed timeline, cautioning that delays could push out expected asset and funding benefits even as the long‑term opportunity remains attractive.
AUM Growth and Deployment Volatility
Assets under management were roughly flat quarter over quarter, a point probed by analysts during the Q&A. Management said capital deployment is inherently variable, with Q1 off‑balance‑sheet deployment of $163.6 million exceeding a suggested modeling range of $130 million to $150 million and surpassing some recent quarters.
Competitive Pressures on Purchase Discounts
Abacus reported that increased buyer competition has compressed purchase discount rates, effectively raising prices paid for policies. While executives framed this as supportive of asset values and exit pricing, they acknowledged that persistent compression could influence spreads and will need close monitoring.
Raised Outlook and Long‑Term Ambitions
In its updated guidance, Abacus reaffirmed confidence in its growth trajectory, backing a higher 2026 adjusted net income range of $100 million to $106 million, with Q2 expected at $24 million to $26 million. Management reiterated long‑term ambitions for $30 billion in assets under management and $250 million in EBITDA by 2028, supported by fundraising momentum, securitization plans and a recourse leverage capacity that could rise from current levels.
Abacus Life’s latest earnings call painted a picture of a company balancing rapid growth with disciplined risk management as it scales a specialized asset class. Investors are likely to focus on whether the firm can sustain strong revenue, maintain attractive portfolio returns and navigate execution risks around funding and competition, but for now momentum appears firmly on its side.